Unknown

Dataset Information

0

Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules.


ABSTRACT: Immunosenescence is characterised by reduced B and T cell responses. Evidence shows that booster vaccinations are less effective in elderly people, but data on the efficacy of primary immunisation are sparse. We conducted a monocentric, open label, phase IV trial to compare immune responses to primary vaccinations using the inactivated, adjuvanted Japanese Encephalitis vaccine by 30 elderly people (mean 69, range 61-78?years) and 30 younger people (mean 24, range 18-30?years). Humoral and cellular immune responses were analysed in relation to age and cytomegalovirus (CMV) seropositivity. Vaccine-specific antibody titres were significantly lower in elderly participants and 47% of them were non- or low responders after the two doses of the vaccine neo-antigen. The reduced humoral immune responses in elderly people correlated with reduced cytokine production, such as interferon gamma (IFN-?) in vitro, as well as higher frequencies of late-differentiated effector and effector memory T cells and T regulatory cells. These cellular changes and lower antibody titres were particularly prominent in CMV-seropositive elderly participants. If primary vaccination before the age of 60 is not possible, elderly patients may require different vaccination strategies to ensure sufficient long-lasting immunity, such as adapted or accelerated schedules and the use of different adjuvants.

SUBMITTER: Wagner A 

PROVIDER: S-EPMC6026142 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules.

Wagner Angelika A   Garner-Spitzer Erika E   Jasinska Joanna J   Kollaritsch Herwig H   Stiasny Karin K   Kundi Michael M   Wiedermann Ursula U  

Scientific reports 20180629 1


Immunosenescence is characterised by reduced B and T cell responses. Evidence shows that booster vaccinations are less effective in elderly people, but data on the efficacy of primary immunisation are sparse. We conducted a monocentric, open label, phase IV trial to compare immune responses to primary vaccinations using the inactivated, adjuvanted Japanese Encephalitis vaccine by 30 elderly people (mean 69, range 61-78 years) and 30 younger people (mean 24, range 18-30 years). Humoral and cellul  ...[more]

Similar Datasets

| S-EPMC10505826 | biostudies-literature
| S-EPMC4636430 | biostudies-literature
| S-EPMC8920407 | biostudies-literature
| S-EPMC10071048 | biostudies-literature
| S-EPMC8314733 | biostudies-literature
| S-EPMC9634255 | biostudies-literature
| S-EPMC11004869 | biostudies-literature
| S-EPMC9275662 | biostudies-literature
| S-EPMC8282116 | biostudies-literature
| S-EPMC8530768 | biostudies-literature